Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19.
Viruses
; 13(4)2021 04 09.
Article
in En
| MEDLINE
| ID: mdl-33918958
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Middle East Respiratory Syndrome Coronavirus
/
SARS-CoV-2
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Language:
En
Journal:
Viruses
Year:
2021
Type:
Article